TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-National, Multi-Center, Double-Blind, Randomized, Parallel Group Study to Compare the Safety and Efficacy of 200 mg PAR-101 Taken q12h With 125 mg Vancomycin Taken q6h for Ten Days in Subjects With Clostridium Difficile-Associated Diarrhea
Brief Summary: This is a comparative study to investigate the safety and efficacy of fidaxomicin versus vancomycin in subjects with Clostridium difficile-Associated Diarrhea (CDAD).


Options:
A: Arm Label: fidaxomicin; Type: EXPERIMENTAL; Interventions: Drug: Fidaxomicin, Drug: Matching Placebo to Fidaxomicin | Arm Label: Vancomycin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vancomycin | Intervention Type: DRUG; Name: Fidaxomicin; Assigned to Arm(s): fidaxomicin | Intervention Type: DRUG; Name: Vancomycin; Assigned to Arm(s): Vancomycin | Intervention Type: DRUG; Name: Matching Placebo to Fidaxomicin; Assigned to Arm(s): fidaxomicin
B: Arm Label: Cadazolid 250 mg; Type: EXPERIMENTAL; Interventions: Drug: Cadazolid, Drug: Placebo-matching vancomycin | Arm Label: Cadazolid 500 mg; Type: EXPERIMENTAL; Interventions: Drug: Cadazolid, Drug: Placebo-matching vancomycin | Arm Label: Cadazolid 1000 mg; Type: EXPERIMENTAL; Interventions: Drug: Cadazolid, Drug: Placebo-matching vancomycin | Arm Label: Vancomycin 125 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vancomycin, Drug: Placebo-matching cadazolid | Intervention Type: DRUG; Name: Cadazolid; Assigned to Arm(s): Cadazolid 1000 mg, Cadazolid 250 mg, Cadazolid 500 mg | Intervention Type: DRUG; Name: Vancomycin; Assigned to Arm(s): Vancomycin 125 mg | Intervention Type: DRUG; Name: Placebo-matching cadazolid; Assigned to Arm(s): Vancomycin 125 mg | Intervention Type: DRUG; Name: Placebo-matching vancomycin; Assigned to Arm(s): Cadazolid 1000 mg, Cadazolid 250 mg, Cadazolid 500 mg
C: Intervention Type: DRUG; Name: tolevamer potassium-sodium (GT267-004); Assigned to Arm(s): N/A
D: Arm Label: Probiotic; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotic | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Probiotic; Assigned to Arm(s): Probiotic | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial Comparing Near Versus Distance Activities While Patching for Amblyopia in Children 3 to <7 Years Old
Brief Summary: Ths purpose of this study is to determine whether "near" activities enhance the effect of patching on visual acuity improvement in strabismic and anisometropic amblyopia when compared with "distance" activities in the treatment of moderate amblyopia and severe amblyopia in children 3 to \<7 years old.


Options:
A: Arm Label: Near activities; Type: ACTIVE_COMPARATOR; Interventions: Device: Eye Patch, Procedure: Near activities | Arm Label: Distance activities; Type: ACTIVE_COMPARATOR; Interventions: Device: Eye Patch, Procedure: Distance activities | Intervention Type: DEVICE; Name: Eye Patch; Assigned to Arm(s): Distance activities, Near activities | Intervention Type: PROCEDURE; Name: Near activities; Assigned to Arm(s): Near activities | Intervention Type: PROCEDURE; Name: Distance activities; Assigned to Arm(s): Distance activities
B: Arm Label: Patching; Type: ACTIVE_COMPARATOR; Interventions: Device: Patching, Procedure: Near activities | Arm Label: Atropine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atropine, Procedure: Near activities | Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): Atropine | Intervention Type: DEVICE; Name: Patching; Assigned to Arm(s): Patching | Intervention Type: PROCEDURE; Name: Near activities; Assigned to Arm(s): Atropine, Patching
C: Intervention Type: DEVICE; Name: Eye patch; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: spectacles; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: atropine; Assigned to Arm(s): N/A
D: Arm Label: Patching; Type: ACTIVE_COMPARATOR; Interventions: Device: Eye Patch | Arm Label: Atropine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atropine | Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): Atropine | Intervention Type: DEVICE; Name: Eye Patch; Assigned to Arm(s): Patching

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial Comparing Near Versus Distance Activities While Patching for Amblyopia in Children 3 to <7 Years Old
Brief Summary: Ths purpose of this study is to determine whether "near" activities enhance the effect of patching on visual acuity improvement in strabismic and anisometropic amblyopia when compared with "distance" activities in the treatment of moderate amblyopia and severe amblyopia in children 3 to \<7 years old.


Options:
A: Intervention Type: DEVICE; Name: Eye patch; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: Spectacles; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): N/A
C: Arm Label: Near activities; Type: ACTIVE_COMPARATOR; Interventions: Device: Eye Patch, Procedure: Near activities | Arm Label: Distance activities; Type: ACTIVE_COMPARATOR; Interventions: Device: Eye Patch, Procedure: Distance activities | Intervention Type: DEVICE; Name: Eye Patch; Assigned to Arm(s): Distance activities, Near activities | Intervention Type: PROCEDURE; Name: Near activities; Assigned to Arm(s): Near activities | Intervention Type: PROCEDURE; Name: Distance activities; Assigned to Arm(s): Distance activities
D: Arm Label: I-BiT Plus; Type: EXPERIMENTAL; Interventions: Device: I-Bit plus | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: I-Bit plus; Assigned to Arm(s): I-BiT Plus

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye As Prescribed Treatments for Amblyopia in Children 3 to <7 Years Old
Brief Summary: The purpose of the study is:

* To compare the effectiveness and safety of weekend atropine augmented with a plano lens for the sound eye versus weekend atropine alone for moderate amblyopia (20/40 to 20/100) in children 3 to less than 7 years old.
* To provide data on the response of severe amblyopia (20/125 to 20/400) to atropine treatment with and without a plano lens.


Options:
A: Intervention Type: DEVICE; Name: Eye patch; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: Spectacles; Assigned to Arm(s): N/A
B: Arm Label: Patching; Type: ACTIVE_COMPARATOR; Interventions: Device: Patching, Procedure: Near activities | Arm Label: Atropine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atropine, Procedure: Near activities | Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): Atropine | Intervention Type: DEVICE; Name: Patching; Assigned to Arm(s): Patching | Intervention Type: PROCEDURE; Name: Near activities; Assigned to Arm(s): Atropine, Patching
C: Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): N/A
D: Arm Label: Atropine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atropine | Arm Label: Atropine plus plano; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atropine, Device: Plano Lens | Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): Atropine, Atropine plus plano | Intervention Type: DEVICE; Name: Plano Lens; Assigned to Arm(s): Atropine plus plano

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye As Prescribed Treatments for Amblyopia in Children 3 to <7 Years Old
Brief Summary: The purpose of the study is:

* To compare the effectiveness and safety of weekend atropine augmented with a plano lens for the sound eye versus weekend atropine alone for moderate amblyopia (20/40 to 20/100) in children 3 to less than 7 years old.
* To provide data on the response of severe amblyopia (20/125 to 20/400) to atropine treatment with and without a plano lens.


Options:
A: Arm Label: I-BiTTM game; Type: EXPERIMENTAL; Interventions: Device: I-BiTTM game | Arm Label: Non-I-BiTTM game; Type: ACTIVE_COMPARATOR; Interventions: Device: Non-I-BiTTM game | Arm Label: I-BiTTM DVD; Type: EXPERIMENTAL; Interventions: Device: I-BiTTM DVD | Intervention Type: DEVICE; Name: I-BiTTM game; Assigned to Arm(s): I-BiTTM game | Intervention Type: DEVICE; Name: Non-I-BiTTM game; Assigned to Arm(s): Non-I-BiTTM game | Intervention Type: DEVICE; Name: I-BiTTM DVD; Assigned to Arm(s): I-BiTTM DVD
B: Arm Label: patching (occlusion therapy); Type: ACTIVE_COMPARATOR; Interventions: Other: patching | Arm Label: binocular games; Type: EXPERIMENTAL; Interventions: Other: binocular games | Intervention Type: OTHER; Name: patching; Assigned to Arm(s): patching (occlusion therapy) | Intervention Type: OTHER; Name: binocular games; Assigned to Arm(s): binocular games
C: Intervention Type: DEVICE; Name: Eye patch; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: spectacles; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: atropine; Assigned to Arm(s): N/A
D: Arm Label: Atropine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atropine | Arm Label: Atropine plus plano; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atropine, Device: Plano Lens | Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): Atropine, Atropine plus plano | Intervention Type: DEVICE; Name: Plano Lens; Assigned to Arm(s): Atropine plus plano

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds
Brief Summary: The purpose of this study is:

* To compare the effectiveness of weekend atropine plus near activities and daily patching plus near activities for moderate amblyopia (20/40 to 20/100) and severe amblyopia (20/125 to 20/400) in improving vision in the amblyopic eye of 7 to \<13 year olds.
* To determine the maximum improvement in vision of the amblyopic eye with each treatment.
* To determine whether amblyopia is associated with structural abnormalities of optic nerve fiber layer.


Options:
A: Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): N/A
B: Intervention Type: DEVICE; Name: 6 hours occlusion by patching; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: 12 hours occlusion by patching; Assigned to Arm(s): N/A
C: Arm Label: Patching; Type: ACTIVE_COMPARATOR; Interventions: Device: Patching, Procedure: Near activities | Arm Label: Atropine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atropine, Procedure: Near activities | Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): Atropine | Intervention Type: DEVICE; Name: Patching; Assigned to Arm(s): Patching | Intervention Type: PROCEDURE; Name: Near activities; Assigned to Arm(s): Atropine, Patching
D: Arm Label: Patching; Type: ACTIVE_COMPARATOR; Interventions: Device: Patching, Procedure: Near activities | Arm Label: Bangerter filters; Type: ACTIVE_COMPARATOR; Interventions: Device: Bangerter filters, Procedure: Near activities | Intervention Type: DEVICE; Name: Bangerter filters; Assigned to Arm(s): Bangerter filters | Intervention Type: DEVICE; Name: Patching; Assigned to Arm(s): Patching | Intervention Type: PROCEDURE; Name: Near activities; Assigned to Arm(s): Bangerter filters, Patching

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds
Brief Summary: The purpose of this study is:

* To compare the effectiveness of weekend atropine plus near activities and daily patching plus near activities for moderate amblyopia (20/40 to 20/100) and severe amblyopia (20/125 to 20/400) in improving vision in the amblyopic eye of 7 to \<13 year olds.
* To determine the maximum improvement in vision of the amblyopic eye with each treatment.
* To determine whether amblyopia is associated with structural abnormalities of optic nerve fiber layer.


Options:
A: Arm Label: Intensive; Type: ACTIVE_COMPARATOR; Interventions: Device: Patching, Drug: Atropine | Arm Label: Weaning; Type: ACTIVE_COMPARATOR; Interventions: Device: Patching, Drug: Atropine | Intervention Type: DEVICE; Name: Patching; Assigned to Arm(s): Intensive | Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): Intensive | Intervention Type: DEVICE; Name: Patching; Assigned to Arm(s): Weaning | Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): Weaning
B: Arm Label: Patching; Type: ACTIVE_COMPARATOR; Interventions: Device: Eye Patch | Arm Label: Atropine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atropine | Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): Atropine | Intervention Type: DEVICE; Name: Eye Patch; Assigned to Arm(s): Patching
C: Intervention Type: DEVICE; Name: Eye patch; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: spectacles; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: atropine; Assigned to Arm(s): N/A
D: Arm Label: Patching; Type: ACTIVE_COMPARATOR; Interventions: Device: Patching, Procedure: Near activities | Arm Label: Atropine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atropine, Procedure: Near activities | Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): Atropine | Intervention Type: DEVICE; Name: Patching; Assigned to Arm(s): Patching | Intervention Type: PROCEDURE; Name: Near activities; Assigned to Arm(s): Atropine, Patching

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds
Brief Summary: The purpose of this study is:

* To compare the effectiveness of weekend atropine plus near activities and daily patching plus near activities for moderate amblyopia (20/40 to 20/100) and severe amblyopia (20/125 to 20/400) in improving vision in the amblyopic eye of 7 to \<13 year olds.
* To determine the maximum improvement in vision of the amblyopic eye with each treatment.
* To determine whether amblyopia is associated with structural abnormalities of optic nerve fiber layer.


Options:
A: Arm Label: Patching; Type: ACTIVE_COMPARATOR; Interventions: Device: Eye Patch | Arm Label: Atropine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atropine | Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): Atropine | Intervention Type: DEVICE; Name: Eye Patch; Assigned to Arm(s): Patching
B: Arm Label: patching (occlusion therapy); Type: ACTIVE_COMPARATOR; Interventions: Other: patching | Arm Label: binocular games; Type: EXPERIMENTAL; Interventions: Other: binocular games | Intervention Type: OTHER; Name: patching; Assigned to Arm(s): patching (occlusion therapy) | Intervention Type: OTHER; Name: binocular games; Assigned to Arm(s): binocular games
C: Arm Label: Patching; Type: ACTIVE_COMPARATOR; Interventions: Device: Patching, Procedure: Near activities | Arm Label: Atropine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atropine, Procedure: Near activities | Intervention Type: DRUG; Name: Atropine; Assigned to Arm(s): Atropine | Intervention Type: DEVICE; Name: Patching; Assigned to Arm(s): Patching | Intervention Type: PROCEDURE; Name: Near activities; Assigned to Arm(s): Atropine, Patching
D: Arm Label: Patching; Type: ACTIVE_COMPARATOR; Interventions: Device: Patching, Procedure: Near activities | Arm Label: Bangerter filters; Type: ACTIVE_COMPARATOR; Interventions: Device: Bangerter filters, Procedure: Near activities | Intervention Type: DEVICE; Name: Bangerter filters; Assigned to Arm(s): Bangerter filters | Intervention Type: DEVICE; Name: Patching; Assigned to Arm(s): Patching | Intervention Type: PROCEDURE; Name: Near activities; Assigned to Arm(s): Bangerter filters, Patching

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Starting Treatment With Agonist Replacement Therapies (START)
Brief Summary: The Food and Drug Administration (FDA) has requested a study comparing buprenorphine/naloxone (BUP/NX) and methadone (MET) on indices of hepatic safety.


Options:
A: Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Arm Label: Buprenorphine/naloxone; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine/naloxone | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone | Intervention Type: DRUG; Name: Buprenorphine/naloxone; Assigned to Arm(s): Buprenorphine/naloxone
B: N/A
C: Arm Label: Buprenorphine/Nx; Type: EXPERIMENTAL; Interventions: Drug: Buprenorphine/naloxone | Arm Label: Methadone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methadone | Intervention Type: DRUG; Name: Buprenorphine/naloxone; Assigned to Arm(s): Buprenorphine/Nx | Intervention Type: DRUG; Name: Methadone; Assigned to Arm(s): Methadone
D: Arm Label: Group A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Probuphine | Arm Label: Group B; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Probuphine; Assigned to Arm(s): Group A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Group B

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Determining Disease Activity Biomarkers in Individuals With Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
Brief Summary: Granulomatosis with polyangiitis (Wegener's) (GPA) and microscopic polyangiitis (MPA) are two rare immune system disorders that cause the inflammation of blood vessels, or vasculitis. In order to properly treat these diseases, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of disease in people with GPA or MPA.


Options:
A: Arm Label: Valaciclovir; Type: ACTIVE_COMPARATOR; Interventions: Drug: Valaciclovir | Arm Label: No additional treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Valaciclovir; Assigned to Arm(s): Valaciclovir
B: Arm Label: mycophenolate mofetil; Type: EXPERIMENTAL; Interventions: Drug: mycophenolate mofetil | Arm Label: cyclophosphamide; Type: ACTIVE_COMPARATOR; Interventions: Drug: cyclophosphamide | Intervention Type: DRUG; Name: mycophenolate mofetil; Assigned to Arm(s): mycophenolate mofetil | Intervention Type: DRUG; Name: cyclophosphamide; Assigned to Arm(s): cyclophosphamide
C: N/A
D: Intervention Type: DRUG; Name: Azathioprine: 2 mg/kg/day; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: methotrexate 0.3 mg/kg/week, to a maximum and optimal dose of 25 mg/week; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Decision Aid to Improve Coronary Heart Disease Risk Modification: a Pilot Randomized Trial
Brief Summary: The purpose of this study is to determine whether providing patients with information about their global coronary heart disease (CHD) risk and effective risk-reducing strategies allows them to make appropriate decisions about heart disease prevention.


Options:
A: Arm Label: Diabetes Medication Choice decision aid; Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes Medication Choice decision aid | Arm Label: Usual Care; Type: OTHER; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Diabetes Medication Choice decision aid; Assigned to Arm(s): Diabetes Medication Choice decision aid | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care
B: Arm Label: Patient Decision Aid for an ICD (primary prevention, non-CRT); Type: EXPERIMENTAL; Interventions: Behavioral: Patient Decision Aid for an ICD (primary prevention, non-CRT) | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Patient Decision Aid for an ICD (primary prevention, non-CRT); Assigned to Arm(s): Patient Decision Aid for an ICD (primary prevention, non-CRT)
C: Intervention Type: DEVICE; Name: Heart-to-Heart Decision Aid; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: video | Intervention Type: OTHER; Name: video; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Decision Aid to Improve Coronary Heart Disease Risk Modification: a Pilot Randomized Trial
Brief Summary: The purpose of this study is to determine whether providing patients with information about their global coronary heart disease (CHD) risk and effective risk-reducing strategies allows them to make appropriate decisions about heart disease prevention.


Options:
A: Intervention Type: DEVICE; Name: Heart-to-Heart Decision Aid; Assigned to Arm(s): N/A
B: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: Other: Case Management | Arm Label: Case Management; Type: EXPERIMENTAL; Interventions: Other: Case Management | Intervention Type: OTHER; Name: Case Management; Assigned to Arm(s): Case Management, Usual Care
C: Arm Label: Algorithm-based care; Type: OTHER; Interventions: Drug: ASA, Atenolol, hydrochlorothiazide, ACE inhibitor, Statin | Arm Label: Health-promotion; Type: OTHER; Interventions: Behavioral: Health Promotion | Intervention Type: DRUG; Name: ASA, Atenolol, hydrochlorothiazide, ACE inhibitor, Statin; Assigned to Arm(s): Algorithm-based care | Intervention Type: BEHAVIORAL; Name: Health Promotion; Assigned to Arm(s): Health-promotion
D: Arm Label: Health check; Type: EXPERIMENTAL; Interventions: Other: Health check | Arm Label: No invitation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Health check; Assigned to Arm(s): Health check

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Decision Aid to Improve Coronary Heart Disease Risk Modification: a Pilot Randomized Trial
Brief Summary: The purpose of this study is to determine whether providing patients with information about their global coronary heart disease (CHD) risk and effective risk-reducing strategies allows them to make appropriate decisions about heart disease prevention.


Options:
A: Intervention Type: DEVICE; Name: Heart-to-Heart Decision Aid; Assigned to Arm(s): N/A
B: Intervention Type: BEHAVIORAL; Name: 6 months readmission rate to hospital; Assigned to Arm(s): N/A
C: Arm Label: Diabetes Medication Choice decision aid; Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes Medication Choice decision aid | Arm Label: Usual Care; Type: OTHER; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Diabetes Medication Choice decision aid; Assigned to Arm(s): Diabetes Medication Choice decision aid | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care
D: Intervention Type: BEHAVIORAL; Name: Re-Mission; Assigned to Arm(s): N/A

Answer: A